Author

E. Douglas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

E. O'Brien· 1 shared F. Lastovka· 1 shared M. B. Avison· 1 shared M. Recker· 1 shared P. Dulyayangkul· 1 shared R. C. Massey· 1 shared R. McLoughlin· 1 shared T. Brignoli· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

E. O'Brien

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Self-sensitisation of Staphylococcus aureus to the antimicrobial factors found in human blood.

E. Douglas, T. Brignoli, M. Recker, E. O'Brien, R. McLoughlin, R. C. Massey

This study identifies genetic factors in Staphylococcus aureus that influence serum survival, revealing how bacterial responses to blood factors affect their transition from commensal to invasive states.

bioRxiv · Jul 19, 2021 · PreprintMicrobiology

Resistance to Ceftazidime/Avibactam Plus Meropenem/Vaborbactam When Both are Used Together Achieved in Four Steps From Metallo-β-Lactamase Negative Klebsiella pneumoniae.

P. Dulyayangkul, E. Douglas, F. Lastovka, M. B. Avison

The paper identifies four genetic steps enabling resistance to the combination of ceftazidime/avibactam and meropenem/vaborbactam in K. pneumoniae.

bioRxiv · Mar 9, 2020Microbiology